宫颈癌根治术后同步放化疗患者高危因素数量的意义
回顾性分析2000至2014年897例IB-IIA期宫颈癌手术患者,其中483例伴高危因素者接受辅助放化疗。单个与多个高危因素患者的5年DFS为80.4%对65.7%(p<0.001),5年OS为87.3%对75.1%(p=0.001),远处转移是最常见复发模式(86.1%)。
要点
- 多个高危因素者5年DFS和OS显著低于单个高危因素者。
- 远处转移是最常见复发模式,占86.1%。
- 腺癌、盆腔淋巴结转移及更高淋巴结转移率是独立不良预后因素。
核心结论
- 早期宫颈癌术后伴多个高危因素、腺癌组织学类型及盆腔淋巴结转移伴更高淋巴结转移率者更易发生隐匿性远处转移。
- 可考虑在辅助治疗后行全身化疗巩固以改善该人群生存结局。
研究设计与样本
- 回顾性研究,纳入2000至2014年897例FIGO IB-IIA期接受手术的宫颈癌患者,其中483例伴高危因素者进行分析。
- 高危因素包括盆腔淋巴结转移、宫旁浸润或切缘受累。
主要发现
- 中位随访57个月(范围6-205个月)。
- 单个与多个高危因素患者5年DFS分别为80.4%和65.7%(p<0.001)。
- 单个与多个高危因素患者5年OS分别为87.3%和75.1%(p=0.001)。
- 远处转移是最常见复发模式(86.1%)。
- 无远处转移生存率单个高危因素为82.7%,多个为68.8%(p<0.001)。
关键数值与推荐
- 多因素分析中,宫旁浸润和切缘受累与预后无关联。
- 腺癌组织学、盆腔淋巴结转移、更高淋巴结转移率及多个高危因素是DFS和OS不良的独立预后因素。
临床怎么用
- 对术后伴多个高危因素、腺癌或盆腔淋巴结转移伴高淋巴结转移率的早期宫颈癌患者,应警惕隐匿性远处转移。
- 可考虑在辅助放化疗后追加全身化疗以改善生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to evaluate the impact of high-risk factors on the survival of patients with cervical cancer treated with surgery followed by adjuvant chemoradiotherapy. METHODS: From 2000 to 2014, medical records of 897 patients with International Federation of Gynecology and Obstetrics stage IB-IIA disease treated with surgery were retrospectively reviewed. Among them, 483 patients with high-risk factors, including pelvic lymph node metastasis, parametrial invasion, or resection margin involvement, were analyzed. RESULTS: The median follow-up time was 57 months (range, 6-205 months). For patients with single and multiple high-risk factors, the 5-year DFS rates were 80.4% and 65.7%, respectively (p < 0.001), and 5-year OS rates were 87.3% and 75.1%, respectively (p = 0.001). Distant metastasis was the most common pattern of recurrence (86.1%). Furthermore, distant metastasis-free survival significantly differed with the number of high-risk factors present (single 82.7% vs. multiple 68.8%, p < 0.001). In the multivariate analysis, while parametrial invasion and resection margin involvement showed no association, the adenocarcinoma histology, pelvic lymph node metastasis, higher metastatic lymph node ratio, and multiple high-risk factors were independent prognosticators associated with poor DFS and OS. CONCLUSIONS: Patients with early-stage cervical cancer having multiple high-risk factors, adenocarcinoma histologic type, and pelvic lymph node metastasis accompanied by a higher lymph node ratio after surgery are more likely to have occult distant metastasis. Further, consolidation with systemic chemotherapy after adjuvant therapy might be considered to improve the survival outcome in this patient population.
引用
- Kim H, Cho WK, Kim YJ, et al. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy. Gynecol Oncol. 2020. PMID: 32139148. doi:10.1016/j.ygyno.2020.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。